Literature DB >> 15678102

RANK-mediated amplification of TRAF6 signaling leads to NFATc1 induction during osteoclastogenesis.

Jin Gohda1, Toru Akiyama, Takako Koga, Hiroshi Takayanagi, Sakae Tanaka, Jun-ichiro Inoue.   

Abstract

RANK and CD40 activate NF-kappaB and MAPKs to similar levels via TRAF6. Even though overexpression of TRAF6 results in osteoclast formation, RANK but not CD40 promotes osteoclastogenesis. To understand the molecular basis for RANK-specific activity in osteoclastogenesis, we created an osteoclast formation system driven by anti-human CD40 antibody-mediated stimulation of a chimeric receptor, h40/mRK, which consists of the extracellular domain of human CD40 and the transmembrane and cytoplasmic domains of mouse RANK. By introducing mutations into three TRAF6-binding sites of RANK, we found that h40/mRK with a single TRAF6-binding site efficiently induced Ca2+ oscillation and expression of NFATc1, a master switch in osteoclastogenesis, whereas CD40 carrying a single TRAF6-binding site did not. However, expression of CD40 that was approximately 100 times greater than that of h40/mRK resulted in osteoclast formation, indicating that the RANK-TRAF6 signal is more potent than the CD40-TRAF6 signal in terms of NFATc1 activation and osteoclastogenesis. These results suggest that RANK may harbor a specific domain that amplifies TRAF6 signaling.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15678102      PMCID: PMC549623          DOI: 10.1038/sj.emboj.7600564

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  42 in total

Review 1.  Tumor necrosis factor receptor-associated factor (TRAF) family: adapter proteins that mediate cytokine signaling.

Authors:  J i Inoue; T Ishida; N Tsukamoto; N Kobayashi; A Naito; S Azuma; T Yamamoto
Journal:  Exp Cell Res       Date:  2000-01-10       Impact factor: 3.905

Review 2.  The molecular architecture of the TNF superfamily.

Authors:  Jean-Luc Bodmer; Pascal Schneider; Jürg Tschopp
Journal:  Trends Biochem Sci       Date:  2002-01       Impact factor: 13.807

3.  Large scale gene expression analysis of osteoclastogenesis in vitro and elucidation of NFAT2 as a key regulator.

Authors:  Norihiro Ishida; Koji Hayashi; Mitsuhiro Hoshijima; Takuya Ogawa; Shintaro Koga; Yuuki Miyatake; Masayoshi Kumegawa; Toru Kimura; Tatsuo Takeya
Journal:  J Biol Chem       Date:  2002-08-08       Impact factor: 5.157

4.  Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts.

Authors:  Hiroshi Takayanagi; Sunhwa Kim; Takako Koga; Hiroshi Nishina; Masashi Isshiki; Hiroki Yoshida; Akio Saiura; Miho Isobe; Taeko Yokochi; Jun-ichiro Inoue; Erwin F Wagner; Tak W Mak; Tatsuhiko Kodama; Tadatsugu Taniguchi
Journal:  Dev Cell       Date:  2002-12       Impact factor: 12.270

5.  Different cytokines induce surface lymphotoxin-alphabeta on IL-7 receptor-alpha cells that differentially engender lymph nodes and Peyer's patches.

Authors:  Hisahiro Yoshida; Asuka Naito; Jun-Ichiro Inoue; Mizuho Satoh; Sybil M Santee-Cooper; Carl F Ware; Atsushi Togawa; Satomi Nishikawa; Shin-Ichi Nishikawa
Journal:  Immunity       Date:  2002-12       Impact factor: 31.745

6.  Possible involvement of IkappaB kinase 2 and MKK7 in osteoclastogenesis induced by receptor activator of nuclear factor kappaB ligand.

Authors:  Aiichiro Yamamoto; Tsuyoshi Miyazaki; Yuho Kadono; Hiroshi Takayanagi; Toshiki Miura; Hiroshi Nishina; Toshiaki Katada; Kenji Wakabayashi; Hiromi Oda; Kozo Nakamura; Sakae Tanaka
Journal:  J Bone Miner Res       Date:  2002-04       Impact factor: 6.741

7.  JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation-dependent and -independent mechanisms.

Authors:  Jean-Pierre David; Kanaga Sabapathy; Oskar Hoffmann; Maria H Idarraga; Erwin F Wagner
Journal:  J Cell Sci       Date:  2002-11-15       Impact factor: 5.285

8.  Molecular interpretation of ERK signal duration by immediate early gene products.

Authors:  Leon O Murphy; Sallie Smith; Rey-Huei Chen; Diane C Fingar; John Blenis
Journal:  Nat Cell Biol       Date:  2002-08       Impact factor: 28.824

9.  A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway.

Authors:  Tewis Bouwmeester; Angela Bauch; Heinz Ruffner; Pierre-Olivier Angrand; Giovanna Bergamini; Karen Croughton; Cristina Cruciat; Dirk Eberhard; Julien Gagneur; Sonja Ghidelli; Carsten Hopf; Bettina Huhse; Raffaella Mangano; Anne-Marie Michon; Markus Schirle; Judith Schlegl; Markus Schwab; Martin A Stein; Andreas Bauer; Georg Casari; Gerard Drewes; Anne-Claude Gavin; David B Jackson; Gerard Joberty; Gitte Neubauer; Jens Rick; Bernhard Kuster; Giulio Superti-Furga
Journal:  Nat Cell Biol       Date:  2004-01-25       Impact factor: 28.824

10.  A RANK/TRAF6-dependent signal transduction pathway is essential for osteoclast cytoskeletal organization and resorptive function.

Authors:  Allison P Armstrong; Mark E Tometsko; Moira Glaccum; Claire L Sutherland; David Cosman; William C Dougall
Journal:  J Biol Chem       Date:  2002-08-15       Impact factor: 5.157

View more
  82 in total

1.  Mitf regulates osteoclastogenesis by modulating NFATc1 activity.

Authors:  Ssu-Yi Lu; Mengtao Li; Yi-Ling Lin
Journal:  Exp Cell Res       Date:  2014-08-22       Impact factor: 3.905

Review 2.  Notch and the regulation of osteoclast differentiation and function.

Authors:  Jungeun Yu; Ernesto Canalis
Journal:  Bone       Date:  2020-06-08       Impact factor: 4.398

3.  Osteoclasts: what do they do and how do they do it?

Authors:  Steven L Teitelbaum
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

Review 4.  Signaling networks that control the lineage commitment and differentiation of bone cells.

Authors:  Carrie S Soltanoff; Shuying Yang; Wei Chen; Yi-Ping Li
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2009       Impact factor: 1.807

5.  The role of T cells in osteoporosis, an update.

Authors:  Wen Zhao; Yuying Liu; Catherine M Cahill; Wenlu Yang; Jack T Rogers; Xudong Huang
Journal:  Int J Clin Exp Pathol       Date:  2009-05-20

6.  Defective entry into mitosis 1 (Dim1) negatively regulates osteoclastogenesis by inhibiting the expression of nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 (NFATc1).

Authors:  Daniel An; Kyunghwan Kim; Wange Lu
Journal:  J Biol Chem       Date:  2014-07-14       Impact factor: 5.157

7.  The scaffold protein RACK1 mediates the RANKL-dependent activation of p38 MAPK in osteoclast precursors.

Authors:  Jingjing Lin; Daekee Lee; Yongwon Choi; Soo Young Lee
Journal:  Sci Signal       Date:  2015-06-02       Impact factor: 8.192

8.  Tacrolimus and cyclosporine A inhibit human osteoclast formation via targeting the calcineurin-dependent NFAT pathway and an activation pathway for c-Jun or MITF in rheumatoid arthritis.

Authors:  Masashi Miyazaki; Yosuke Fujikawa; Chikahiro Takita; Hiroshi Tsumura
Journal:  Clin Rheumatol       Date:  2006-04-04       Impact factor: 2.980

9.  Platelet-derived growth factor BB enhances osteoclast formation and osteoclast precursor cell chemotaxis.

Authors:  Dian-Qi Li; Qi-Long Wan; Janak L Pathak; Zu-Bing Li
Journal:  J Bone Miner Metab       Date:  2016-09-14       Impact factor: 2.626

10.  Mitf induction by RANKL is critical for osteoclastogenesis.

Authors:  Ssu-Yi Lu; Mengtao Li; Yi-Ling Lin
Journal:  Mol Biol Cell       Date:  2010-03-31       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.